Printer Friendly

Articles from Stem Cell Lab World (October 6, 2014)

1-19 out of 19 article(s)
Title Author Type Words
Better way to create pluripotent stem cells from adult cells. 689
Capricor to pursue clinical program for treatment of Duchenne muscular dystrophy. 160
Cardio3 biosciences discusses new business development strategy. 102
Cell isolation/separation market to hit $5.1 b by 2019. 376
Companies agree to joint development of therapy for stroke. 321
Final patient treated in Stargardt's macular degeneration phase 1 trial in U.K. 130
Global biotech market to grow at CAGR of 16.7 percent. 452
Global stem cell therapy market growing at 39.5 percent CAGR. Industry overview 535
Graft versus host disease market to reach $409 m in four years. 357
ISCO reports on status of Parkinson's disease program. 227
JCR pharmaceuticals files for Japanese marketing approval of stem cell product. 215
Kadimastem reports to FDA on results of preclinical ALS treatment studies. 213
Last patient treated in BrainStorm's phase 2a ALS study. 202
Researchers receive $5.8 m federal grant to build 3D liver model. 413
Stemedica: patent for use of multiple stem cell lines to treat ischemic stroke. 257
Stemgent sells stem cell reagent and services business unit. Company overview 176
Therapy-grade stem cells created using new cocktail to reprogram adult cells. 452
U.K. technology centre to develop smart cell processing technologies. 256
Using skin cells to engineer pulmonary valves for pediatric heart patients. 411

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |